May & Baker Nigeria

May & Baker Nigeria, established in 1944, is a prominent pharmaceutical and beverage entity operating within the African market. The company maintains a robust portfolio, specializing in the production of anti-diabetic, anti-hypertensive, and anti-infective medications. Beyond its core pharmaceutical manufacturing, the organization has diversified into the beverage sector and personal care products, including hand sanitizers. By leveraging advanced manufacturing capabilities, May & Baker Nigeria serves both healthcare providers and individual consumers with high-quality, reliable health solutions.

The company generates $25.7M in annual revenue, supporting its operations across 4 distinct locations with a workforce of 500-1,000 employees. This operational scale supports its dual-focus business model, which encompasses pharmaceutical manufacturing and beverage production. The firm’s infrastructure is designed to meet rigorous international standards, ensuring consistent output across its various product lines. With a long-standing history of industrial presence, the company continues to optimize its supply chain and production efficiency to meet the evolving demands of the healthcare sector in Nigeria and the broader region.

Quality assurance remains a cornerstone of the company's strategy, evidenced by its World Health Organization (WHO) Good Manufacturing Practice (GMP) certification. This commitment to international best practices positions the firm as a trusted partner in the pharmaceutical landscape. The organization’s subsidiaries focus on specialized areas such as vaccine production and the development of healthcare brands. Meet May & Baker Nigeria's team to understand the leadership and technical expertise driving these initiatives. Through its focus on contract manufacturing services and high-standard pharmaceutical production, the company sustains its competitive edge in theView more...